Nabil Sabbak, MD
Interventional Cardiology · Marietta, GANPI 1225492119
Payments from drug & device makers
Across 205 payments — averaging $122.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$11K
- Edwards Lifesciences$6K
- Boston Scientific$4K
- Abbott$3K
- Medtronic$706
- Cardiovascular Systems Inc.$289
- plus $437 from 7 others
What the payments were for
- Consulting fees$2,50018%
- Travel & lodging$5,05136%
- Food & beverage$6,16144%
- Education$2142%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 54 | $11,249 |
| Edwards Lifesciences | 47 | $5,687 |
| Boston Scientific | 30 | $4,239 |
| Abbott | 43 | $2,569 |
| Medtronic | 13 | $706 |
| Cardiovascular Systems Inc. | 4 | $289 |
| Shockwave Medical, Inc | 4 | $241 |
| Cardiva Medical, Inc. | 3 | $64 |
| W. L. Gore & Associates, Inc. | 2 | $48 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $25 |
| Amgen | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Biotronik Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vitalyst$3,471
- EVOQUE$1,572
- MitraClip$876
- SAPIEN 3 Ultra RESILIA$683
- AMPLATZER$258
- Diamondback Coronary$222
- RESOLUTE ONYX$214
- GENERAL - THERAPIES$187
- OPTIS$171
- PORTICO$164
- SYMPLICITY G3$163
- DRAGONFLY OPSTAR$162
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$156
- PASCAL$145
- XIENCE SKYPOINT$133
- NAVITOR$115
- PRESSUREWIRE$107
How this compares
$25,176 in reported general payments places this provider in the 65th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 24 | $179 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Marietta
- Amar PatelMarietta$1.8M
- Salvatore ManninoMarietta$669K
- Paul GuichardMarietta$377K
- Arthur ReitmanMarietta$275K
- Ahmed Al BadriMarietta$110K
- David KandzariAtlanta$3.7M
- Pradeep YadavAtlanta$3.5M
- Vasilis BabaliarosAtlanta$2.7M
- Megan CoylewrightCalhoun$2.3M
- William NicholsonAtlanta$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.